Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 11
Submit an article Journal homepage
996
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

SARS-CoV-2 in multiple myeloma: initial observation and management

Elisabet E. Manasancha Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
,
Victor Mulanovichb Department of Internal Medicine/Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Joanna-Grace Manzanob Department of Internal Medicine/Infectious Disease, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Maria Susan Gaetac Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Melody Becnela Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Gregory P. Kaufmana Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Hans C. Leea Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Behrang Aminid Radiodiagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sheeba K. Thomasa Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Swaminathan P. Iyera Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Donna M. Webera Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Zuzana Berkovaa Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Christopher R. Flowersa Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Robert Z. Orlowskia Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Krina K. Patela Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
 show all
Pages 2763-2766 | Received 20 May 2020, Accepted 05 Jun 2020, Published online: 17 Jun 2020

References

  • Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). Treasure Island (FL): StatPearls; 2020.
  • Pratt G, Goodyear O, Moss P. Immunodeficiency and immunotherapy in multiple myeloma. Br J Haematol. 2007;138(5):563–579.
  • Blimark C, Holmberg E, Mellqvist UH, et al. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015;100(1):107–113.
  • Zhang X, Song K, Tong F, et al. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab. Blood Adv. 2020;4(7):1307–1310.
  • Salako O, Okunade K, Allsop M, et al. Upheaval in cancer care during the COVID-19 outbreak. Ecancermedicalscience. 2020;14. doi:10.3332/ecancer.2020.ed97
  • Ohe M, Shida H, Jodo S, et al. Macrolide treatment for COVID-19: will this be the way forward? Biosci Trends. 2020;14(2):159–160.
  • Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020. doi:10.1016/j.ijantimicag.2020.105949
  • Zhou Y, Fu B, Zheng X, et al. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID19 patients. Natl Sci Rev. 2020. doi:10.1093/nsr/nwaa041
  • Adam Monteagudo L, Boothby A, Gertner E. Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome. ACR Open Rheuma. 2020;2(5):276–282.
  • Wampler Muskardin TL. IV anakinra for macrophage activation syndrome may hold lessons for treatment of cytokine storm in the setting of COVID19. ACR Open Rheuma. 2020;2(5):283–285.
  • Luo P, Liu Y, Qiu L, et al. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol. 2020;92(7):814–818.
  • Yancy CW. COVID-19 and African Americans. JAMA. 2020;323(19):1891.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.